 |
|
|
|
|
Gerold Schuler, M.D.
Gerold Schuler, M.D., director and chairman of the Department of Dermatology,
University Hospital of Erlangen, devotes much of his research to the study
of the human immune system, in particular cellular immunity. Schuler has
published research on dendritic cell (DC) maturation, the production of
Interleukin-12 via DCs and myeloid DCs. He has also published studies on
the first “proof of principle” that DC tumor specific cytotoxic
and Type 1 helper T-cells can be induced in vitro and in vivo in humans,
the first functional characterization of the CD83 molecule on DC, and the
identification of regulatory T cells. Schuler received his M.D., with distinction,
at Leopold-Franzens-University of Innsbruck, Austria in 1975. He completed
his research fellowship at the Institute for Histology and Embryology and
Institute for Biochemical Pharmacology, University of Innsbruck, Austria
in 1977.
|
|
 |
|
